Lohit Garg

Lohit Garg

Auto-generated profile, based on publicly available information

Lohit Garg

Division of Cardiac Electrophysiology, University of Colorado Anschutz Medical Campus, Aurora, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2018 in Heart Failure Reviews
Verified
Journal Article
Closed access
PDF file
LGLohit Garg
Lohit Garg
MGManasvi Gupta
Manasvi Gupta
SSSyed Rafay Ali Sabzwari
Syed Rafay Ali Sabzwari
SASahil Agrawal
Sahil Agrawal
MAManyoo Agarwal
Manyoo Agarwal
MMMatthew W. Martinez
Matthew W. Martinez

18 April 2017 in Heart Failure Reviews
Verified
Journal Article
Closed access
PDF file
LGLohit Garg
Lohit Garg
GAGhulam Akbar
Ghulam Akbar
SASahil Agrawal
Sahil Agrawal
MAManyoo Agarwal
Manyoo Agarwal
LKLeila Khaddour
Leila Khaddour
BDBhavinkumar D. Dalal
Bhavinkumar D. Dalal

1 November 2016 in International Journal of Cardiology
Verified
Journal Article
Closed access
LGLohit Garg
Lohit Garg
CCCharity Chen
Charity Chen
DHDavid E. Haines
David E. Haines

1 June 2019 in Journal of Interventional Cardiac Electrophysiology
Verified
Journal Article
Closed access
PDF file
JJJinu John
Jinu John
LGLohit Garg
Lohit Garg
MOMolly Orosey
Molly Orosey
TDTusar Desai
Tusar Desai
DHDavid E Haines
David E Haines
WWWai Shun Wong
Wai Shun Wong

17 July 2018 in Clinical Cardiology
Verified
Journal Article
Closed access
PDF file
MSMahek Shah
Mahek Shah
SPSoumya Patnaik
Soumya Patnaik
OMObiora Maludum
Obiora Maludum
BPBrijesh Patel
Brijesh Patel
BTByomesh Tripathi
Byomesh Tripathi
MMMatthew W. Martinez
Matthew W. Martinez

18 September 2021 in Current Treatment Options in Cardiovascular Medicine
Verified
Journal Article
Open access
PDF file
LELauren A Eberly
Lauren A Eberly
LGLohit Garg
Lohit Garg
MVMahesh Vidula
Mahesh Vidula
NRNosheen Reza
Nosheen Reza
SKSheela Krishnan
Sheela Krishnan
Purpose of review The purpose of this review is to summarize what is known about the relationship between exercise and arrhythmogenic right ventricular cardiomyopathy (ARVC) with regard to disease onset, diagnosis, progression, and clinical severity. This relationship forms the basis of the management recommendations for restricting physical activity in individuals with and at risk for ARVC. Recent findings While ARVC can be challenging to diagnose, there are several diagnostic testing and imaging modalities that may help distinguish athletic heart remodeling from ARVC. There is an increased risk of adverse clinical outcomes in ARVC from endurance and competitive sports participation, including a dose-dependent relationship between exercise intensity and risk of disease penetrance and progression. Summary High-intensity exercise can lead to earlier disease onset, increased penetrance, and clinical progression among individuals with and at risk for ARVC. Both amount and intensity of exercise are correlated with adverse outcomes, including ventricular arrhythmias and worsening biventricular function. All individuals with and at risk for ARVC should undergo detailed clinical phenotyping and risk stratification to reduce the risk of such outcomes, including sudden cardiac death. Consensus guidelines recommend against participation in competitive or high-intensity and endurance exercise for individuals with and at risk for ARVC.